Amarin Corporation plc (NASDAQ:AMRN) does about 5.79M shares in volume on a normal day but saw 7726420 shares change hands in Friday trading. The company now has a market cap of 2.95B USD and an enterprise value of about $2.46B. Its current market price is $7.36, marking a decrease of -3.66% compared to the previous close of $7.64. The 52 week high reached by this stock is $26.12 whilst the lowest price level in 52 weeks is $3.95. The script in recent trading has seen the stock touch a high of $7.72 and a low of $7.30.
Amarin Corporation plc (AMRN) has a 20-day trading average at $6.93 and the current price is -71.82% off the 52-week high compared with 86.33% distance from its 52-week low. The 50-day simple moving average of the closing price is $6.82 and its 200-day simple moving average is $12.34. If we look at the stock’s price movements over the week, volatility stands at 6.44%, which decreases to 5.23% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 59.55 to suggest the stock is neutral.
12 analysts observing the Amarin Corporation plc (AMRN) stock have set the 12-month price targets for the company’s shares at between $8.00 and $35.00. The median price target is 29.9% away from the current levels at $10.50.
FactSet Research has provided data showing that 12 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 8 analysts have rated it as a buy and 4 have advised that investors hold their positions. The consensus recommendation rating is Overweight and Wall Street’s advice is for investors to Moderate Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on August 26, 2020 when Piper Sandler initiated the stock to “Overweight” and issued a price target of $21.
The current price level is 6.90%, 8.14%, and -40.56% away from its SMA20, SMA50, and SMA200 respectively, with the AMRN price moving below the 50-day SMA on August 28. Amarin Corporation plc (AMRN) stock is up 6.51% over the week and 11.68% over the past month. Its price is -65.67% year-to-date and -51.16% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/29/2020, with the company’s earnings per share (EPS) of $0.01 above consensus estimates by $0.08. The company’s next earnings report is expected on 10/29/2020, with forecasts estimating quarterly EPS at $0.01 and -$0.01 for whole year. AMRN’s earnings per share are forecast to grow by 85.70% this year and 4,900.00% over next year. Expected sales for next quarter are $177.06 million, which analysts say will come at $622.72 million for the current fiscal year and next year at $866.43 million. In addition, estimates put the company’s current quarterly revenue at an average of $155.49 million.
Its 12-month price target is $10.50. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $8.00, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $35.00.
Outstanding shares total 384.66M with insiders holding 0.99% of the shares and institutional holders owning 43.74% of the company’s common stock. The company has a return on investment of -3.80% and return on equity of -2.20%. The forward price to earnings ratio is 15.18. The beta has a value of 2.66. Price to book ratio is 4.75 and price to sales ratio is 5.40.
According to a U.S. Securities and Exchange Commission filing, Artisan International Fund has reduced its position in Amarin Corporation plc (AMRN) to 6,468,636 shares, mirroring a recent drop by -2.23%. Artisan International Fund dumped -0.15 million shares of Amarin Corporation plc common stock bringing its total worth to about $41.92 million at the end of recent close, SEC documents show. Artisan International Fund isn’t the only investment manager who changed stakes and is followed by iShares NASDAQ Biotechnology ETF, which sold off 28611.0 shares to end up with 3,709,185 shares worth $24.04 million. Federated Hermes Kaufmann Small C raise their holdings by 113.41% in the company over the course of the most recent quarter. It now holds a 0.91% position in Amarin Corporation plc thanks to 3.5 million shares amounting to $22.68 million.